http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1328538-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
filingDate 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e3602e10065d3f76a52e195aea6223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65b2015f2cf5e26b641013aeb4915143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69e0826dbdf6192a2508e71b82c85038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613d60b46b8f999de20445e5550ce038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acce8abaec5ec9e2b31e147d0b6e0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_381074e825b1467edec3114f879b71e9
publicationDate 2003-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1328538-A1
titleOfInvention Process and intermediates for the production of 7-substituted antiestrogens
abstract A process for preparing an intermediate compound of formula (II): where X is as defined in the specification, R1 is haloalkyl, alkyl, alkenyl, cycloalkyl, carboxyalkyl, alkoxycarbonylalkyl, aryl or arylalkyl; R?2, R3, R4 and R5¿ are organic groups as defined in the specification, which process comprises aromatisation of a compound of formula (III): where R?1, R2, R3¿, n X and R5 are as defined in relation to formula (II) and R4 is a group R4 or a precursor group thereof, and thereafter if necessary or desired, carrying out one or more of the following steps: (i) removing any hydroxy protecting groups R; (ii) converting a precursor group R4' to a group R4, or where R4' is a group R4, converting it to a different such group. Compounds obtained are useful intermediates for example in the preparation of fulvestrant. Novel intermediates are also claimed.
priorityDate 2000-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20437628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418354341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452833283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226700128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452190657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422000484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226700127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10220139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456001950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87097651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25203914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57300161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87097652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 79.